Uncategorized

PISCATAWAY, NEW JERSEY – Signia today announced that it is holding its second virtual Signia Student University (SSU) event, featuring several in-depth and interactive sessions that deliver key insights and knowledge for audiology doctorate program students. The free program will kick-off with a live welcome event on December 6th at 6:00 pm ET led by Mike O’Neil, President of Signia

BOSTON, MASSACHUSSETTS — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, has announced the submission of Clinical Trial Applications (CTAs) to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom and the Spanish Agency of Medicines and Medical Devices (AEMPS) for a Phase

MONTPELLIER, FRANCE — Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, announces that the US Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to the Company’s lead therapy gene candidate, OTOF-GT, a gene therapy intended for the treatment of otoferlin

HAMILTON, BERMUDA — Altamira Therapeutics Ltd. (formerly known as Auris Medical), a company dedicated to developing therapeutics that address important unmet medical needs, has announced that it has entered into an agreement regarding the sale of certain of its legacy assets comprised of its inner ear therapeutics research and development programs and a license to use its RNA delivery technology

PARIS, FRANCE — M. Charles Liberman, PhD, whose research forever changed the way experts understand  the underlying causes of hearing loss, has been awarded the Scientific Grand Prize from the France-based La Fondation Pour l’Audition. The award is one of the highest honors given in hearing science and was presented to Dr. Liberman in a ceremony in Paris, France, on

New York — Yes Hearing, a leading provider of affordable, accessible, and convenient hearing technology and audiology care, today announced that it closed a $10M Series A financing round. The investment was led by Blue Heron Capital with participation from Primetime Partners, Ensemble Innovation Ventures, Maccabee Ventures & Gaingels. “Hearing care is a critical component of healthy aging. The unique challenge with hearing loss is that we

EDEN PRAIRIE, MINNESOTA – Starkey had the privilege of hosting a group of local Special Olympics athletes and their families, along with leaders from Special Olympics Minnesota, in its U.S. Bank Stadium turf suite for the Minnesota Vikings®. In addition to watching the game from one of the closest suites in the NFL, the group was visited by the Minnesota

Uh-oh, the holiday season is on us! Halloween was yesterday, and Thanksgiving, Remembrance Day, Winter Solstice, Hanukkah, Christmas, New Year’s and a few others are still ahead.   At this point in the calendar, most people are, like, yay-hooray! But others, the ones who have hearing loss, have a little dread and nervousness mixed in with the excitement. It’s not

LONE TREE, COLORADO — Cochlear Limited (ASX: COH), a global leader in implantable hearing solutions, has announced U.S. Food and Drug Administration (FDA) approval for the Cochlear™ Nucleus® 8 Sound Processor. According to the company, the Nucleus 8 Sound Processor is now the smallest and lightest behind-the-ear cochlear implant sound processor available in the industry.1-3 It is also the world’s first cochlear implant sound processor